Ark Pharmacy (06086.HK) officially launched its offering on June 28th, offering 23.8 million shares globally, 2.38 million shares in Hong Kong, and 21.42 million shares in international markets, with an additional 15% over-allotment option. Citigroup and Agricultural Bank of China International are joint sponsors. The expected shares will begin trading on the Main Board of the Hong Kong Stock Exchange on July 9, 2024.
Let's take a closer look at the IPO situation of Ark Pharmacy (6086.HK) below.